Miyazaki K - Search Results

1

Infectious complications after gastric cancer surgery accelerate a rapid hepatic recurrence.

Ohtsuka T, Kitajima Y, Takahashi T, Sato S, Miyoshi A, Kohya N, Kitahara K, Nakafusa Y, Miyazaki K. Ohtsuka T, et al. Among authors: miyazaki k. Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1277-80. Hepatogastroenterology. 2009. PMID: 19950777

2

Modification of lymph node dissection for colon cancer by clinical diagnosis.

Nakafusa Y, Tanaka T, Kitajima Y, Sato S, Hirohashi Y, Miyazaki K. Nakafusa Y, et al. Among authors: miyazaki k. Hepatogastroenterology. 2004 May-Jun;51(57):722-6. Hepatogastroenterology. 2004. PMID: 15143901

3

The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer.

Koga Y, Kitajima Y, Miyoshi A, Sato K, Sato S, Miyazaki K. Koga Y, et al. Among authors: miyazaki k. J Gastroenterol. 2006 Feb;41(2):133-9. doi: 10.1007/s00535-005-1732-7. J Gastroenterol. 2006. PMID: 16568372

4

Significance of pancreatic exocrine function in the perioperative management of pancreatoduodenectomy.

Ohtsuka T, Kitahara K, Matsuyama S, Shimonishi T, Nakafusa Y, Miyazaki K. Ohtsuka T, et al. Among authors: miyazaki k. Hepatogastroenterology. 2006 Sep-Oct;53(71):788-91. Hepatogastroenterology. 2006. PMID: 17086890

5

False-positive findings for tumor markers after curative gastrectomy for gastric cancer.

Ohtsuka T, Sato S, Kitajima Y, Tanaka M, Nakafusa Y, Miyazaki K. Ohtsuka T, et al. Among authors: miyazaki k. Dig Dis Sci. 2008 Jan;53(1):73-9. doi: 10.1007/s10620-007-9825-1. Epub 2007 May 3. Dig Dis Sci. 2008. PMID: 17476595

6

Comparison of the postoperative outcome after a pancreatoduodenectomy using the Billroth I and II type of reconstruction.

Ohtsuka T, Kitahara K, Matsuyama S, Shimonishi T, Nakafusa Y, Miyazaki K. Ohtsuka T, et al. Among authors: miyazaki k. Hepatogastroenterology. 2007 Jul-Aug;54(77):1570-4. Hepatogastroenterology. 2007. PMID: 17708302

7

Different roles of tumor marker monitoring after curative resections of gastric and colorectal cancers.

Ohtsuka T, Nakafusa Y, Sato S, Kitajima Y, Tanaka M, Miyazaki K. Ohtsuka T, et al. Among authors: miyazaki k. Dig Dis Sci. 2008 Jun;53(6):1537-43. doi: 10.1007/s10620-007-0046-4. Dig Dis Sci. 2008. PMID: 17932750

8

Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer.

Kitajima Y, Ohtaka K, Mitsuno M, Tanaka M, Sato S, Nakafusa Y, Miyazaki K. Kitajima Y, et al. Among authors: miyazaki k. Oncol Rep. 2008 Jan;19(1):197-202. Oncol Rep. 2008. PMID: 18097595

9

[Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer].

Kitajima Y, Yakabe T, Ohtsuka T, Tanaka M, Sato S, Nakafusa Y, Miyazaki K. Kitajima Y, et al. Among authors: miyazaki k. Gan To Kagaku Ryoho. 2009 May;36(5):851-4. Gan To Kagaku Ryoho. 2009. PMID: 19461193 Japanese.

10

Efficacy of major hepatectomy for large hepatocellular carcinoma.

Miyoshi A, Takahashi T, Otsuka T, Kohya N, Miyazaki K. Miyoshi A, et al. Among authors: miyazaki k. Hepatogastroenterology. 2009 May-Jun;56(91-92):768-72. Hepatogastroenterology. 2009. PMID: 19621699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,673 results

Search Page

Filters